FTE Networks to Ring the New York Stock Exchange Opening Bell on January 10, 2018
Jan 08, 2018 13:31 pm UTC| Business
NAPLES, Fla., Jan. 08, 2018 -- FTE Networks, Inc. (NYSE American:FTNW) ("FTE" or the "Company"), a leading provider of innovative technology-oriented solutions for smart platforms, network infrastructure and buildings,...
Anthera Pharmaceuticals Announces Results of Special Meeting of Stockholders
Jan 08, 2018 13:31 pm UTC| Business
HAYWARD, Calif., Jan. 08, 2018 -- Anthera Pharmaceuticals, Inc. (Nasdaq:ANTH) is pleased to announce the results of the Special Meeting of Stockholders held on January 5, 2018. Shareholders approved all of the proposed...
Link Reservations’ Cryptolus.com to Implement Security Infrastructure
Jan 08, 2018 13:31 pm UTC| Business
NEW YORK, NY, Jan. 08, 2018 -- Link Reservations, Inc. (OTC PINK: LRSV), a technology development company, is pleased to announce a technology partnership to deliver high-assurance security infrastructure for crypto...
Notice of Plaintiffs’ Proposed Voluntary Dismissal of Shareholder Derivative Actions
Jan 08, 2018 13:31 pm UTC| Business
SALT LAKE CITY, Jan. 08, 2018 -- This notice relates to a proposed voluntary dismissal by the plaintiffs in each of four pending shareholder derivative actions, and is being given pursuant to an order of The United...
Jan 08, 2018 13:31 pm UTC| Business
PHOENIX, Jan. 08, 2018 -- Uptick Newswire is the sole producer of the Uptick Network “Stock Day” Podcast that updates investors and shareholders on the micro-cap sector of the market. After airing back in January 2016...
Jan 08, 2018 13:31 pm UTC| Business
MOUNTAIN VIEW, Calif., Jan. 08, 2018 -- ChemoCentryx, Inc., (Nasdaq:CCXI), a biopharmaceutical company developing new medications targeted at inflammatory and autoimmune diseases and cancer, today announced the...
Jan 08, 2018 13:31 pm UTC| Business
WATERTOWN, Mass., Jan. 08, 2018 -- pSivida Corp. (NASDAQ:PSDV) (ASX:PVA), a leader in the development of sustained release drug products and technologies, today announced it has submitted its New Drug Application (NDA)...